245 filings
Page 5 of 13
PRER14C
141kh
10 May 21
Preliminary revised information
4:44pm
8-K
8rrkjy
10 May 21
BioVie Announces Amended Terms for Asset Acquisition from Privately Held NeurMedix
8:38am
PREM14C
snhrt3uc1w406 osc
4 May 21
Preliminary information related to merger
5:23pm
8-K
hbj0w
29 Apr 21
Regulation FD Disclosure
8:25am
8-K
pb5nr1yw8fcipjmpae4s
27 Apr 21
BioVie Acquires Biopharma Assets from Privately Held NeurMedix
5:19pm
EFFECT
2wqkfhnay960
3 Feb 21
Notice of effectiveness
12:15am
CORRESP
n6wze2dq0
1 Feb 21
Correspondence with SEC
12:00am
UPLOAD
suf t9fv78wndi3vccu
29 Jan 21
Letter from SEC
12:00am
S-3
5qi4u
25 Jan 21
Shelf registration
2:31pm
8-K
nkw86v
23 Sep 20
BioVie Announces Closing of Public Offering of Common Stock
8:11am
424B4
rv0wny6 uvy0zcbp2
18 Sep 20
Prospectus supplement with pricing info
7:13am
EFFECT
1enl5a 5rpd7g9
18 Sep 20
Notice of effectiveness
12:15am
UPLOAD
avfz6a
18 Sep 20
Letter from SEC
12:00am
S-1MEF
jnfnt
17 Sep 20
Registration of additional securities for an S-1
9:20pm
CERT
951mrw9qud8o8mneby
17 Sep 20
Certification of approval for exchange listing
4:45pm
CORRESP
03shb0g2g5y
16 Sep 20
Correspondence with SEC
12:00am
CORRESP
3amtvov jph
16 Sep 20
Correspondence with SEC
12:00am